ADD ANI AS A TRUSTED SOURCE
googleads
Menu
Health

Eating small amounts of peanut after immunotherapy may extend allergy treatment benefits: Study

Washington D.C. [USA], Feb 25 (ANI): Dietary consumption of peanut after completing oral immunotherapy (OIT) or sublingual immunotherapy (SLIT) for peanut allergy may actually provide continued protection against accidental exposures to the allergen, according to a new study led by Edwin Kim.

ANI Feb 25, 2019 13:09 IST googleads

Representative Image

Washington D.C. [USA], Feb 25 (ANI): Dietary consumption of peanut after completing oral immunotherapy (OIT) or sublingual immunotherapy (SLIT) for peanut allergy may actually provide continued protection against accidental exposures to the allergen, according to a new study led by Edwin Kim.
The findings were presented in the annual American Academy of Allergy, Asthma and Immunology (AAAAI) conference in San Francisco.
The study followed 55 people who had completed OIT or SLIT peanut immunotherapy trials at UNC-Chapel Hill and were desensitised to between 300mg and 5,000mg of peanut.
Notably, Desensitisation increases the amount of peanut it takes to cause an allergic reaction, decreasing the likelihood of a severe reaction caused by accidental peanut exposure.
Speaking about it, Kim said, “They don't necessarily want to eat large amounts of their allergen, they just want a level of reassurance that if a restaurant cook makes a mistake or a food label is wrong, they won't have a severe allergic reaction."
After completing their immunotherapy trial, participants were encouraged to introduce foods containing peanuts into their diets with a goal of about 300 mg of peanut each day. As part of their long-term follow-up, participants were asked to report how much they ate, how often they ate it and how they felt afterward.
The majority of participants continued regularly eating peanuts daily for up to eight years after completing immunotherapy.
Among those still eating peanuts, the median amount of daily consumption was 600 mg. No reactions from accidental ingestions were reported for the 55 participants, but ten people reported allergic reactions to the daily peanut foods they introduced into their diet. (ANI)
The majority of reactions were mild and treated with antihistamines, however three reactions required epinephrine and two required EMS.
Although these more significant reactions were infrequent, it is a reminder that incorporation of dietary peanut in this capacity should only be done under the guidance of an allergist.
Kim says more longitudinal studies need to be done, but he and colleagues are hopeful this research can be applied to other types of food allergies. (ANI)

Get the App

What to Read Next

Health

Injection turns sleeping tumour immune cells into cancer fighters

Injection turns sleeping tumour immune cells into cancer fighters

The Korea Advanced Institute of Science and Technology (KAIST) researchers have developed a way to reprogram immune cells already inside tumours into cancer-killing machines.

Read More
Health

Ageing reduces CAR-T cell effectiveness by impairing metabolism

Ageing reduces CAR-T cell effectiveness by impairing metabolism

People's immune systems deteriorate as they age, making cancer therapies that rely on immune cells difficult to implement. In a new study, researchers from the University of Lausanne (UNIL), the Lausanne University Hospital (CHUV), the Geneva University Hospitals (HUG), and the Ecole Polytechnique Federale de Lausanne (EPFL) show that age-related immune decline has a measurable impact on CAR-T cell therapy, one of the most advanced forms of cancer immunotherapy.

Read More
Health

Study shows how allergies differ in urban, rural children

 Study shows how allergies differ in  urban, rural children

Scientists discovered that a previously uncharacterized subset of immune cells may play an important role in the development of allergy illnesses and explain disparities between urban and rural populations.

Read More
Health

Antibody reduces tumor growth in ovarian cancers: Study

Antibody reduces tumor growth in ovarian cancers: Study

Immunotherapy, or antibody treatment that activates the patient's own immune system against cancer, is increasingly being studied as an alternative to chemotherapy and radiotherapy. This is because it directly targets cancer cells, reducing the negative effects associated with more conventional treatments.

Read More
Health

Research unlocks key to long-lasting immune response in cancer

Research unlocks key to long-lasting immune response in cancer

Prolonged illnesses, such as cancer and persistent infections, can fatigue the immune system, causing its frontline defenders, T cells, to lose their ability to act efficiently.

Read More
Home About Us Our Products Advertise Contact Us Terms & Condition Privacy Policy

Copyright © aninews.in | All Rights Reserved.